1	Epstein-Barr	epstein-barr	_	_	_	_	_	_	_
2	virus	virus	_	_	_	_	_	_	_
3	nuclear	nuclear	_	_	_	_	_	_	_
4	antigen	antigen	_	_	_	_	_	_	_
5	2	2	_	_	_	_	_	_	_
6	transactivates	transactivate	_	_	_	_	_	_	_
7	latent	latent	_	_	_	_	_	_	_
8	membrane	membrane	_	_	_	_	_	_	_
9	protein	protein	_	_	_	_	_	_	_
10	LMP1	lmp1	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	Several	several	_	_	_	_	_	_	_
2	lines	line	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	evidence	evidence	_	_	_	_	_	_	_
5	are	be	_	_	_	_	_	_	_
6	compatible	compatible	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	hypothesis	hypothesis	_	_	_	_	_	_	_
10	that	that	_	_	_	_	_	_	_
11	Epstein-Barr	epstein-barr	_	_	_	_	_	_	_
12	virus	virus	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	EBV	EBV	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	nuclear	nuclear	_	_	_	_	_	_	_
17	antigen	antigen	_	_	_	_	_	_	_
18	2	2	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	EBNA-2	ebna-2	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	or	or	_	_	_	_	_	_	_
23	leader	leader	_	_	_	_	_	_	_
24	protein	protein	_	_	_	_	_	_	_
25	(	(	_	_	_	_	_	_	_
26	EBNA-LP	EBNA-LP	_	_	_	_	_	_	_
27	)	)	_	_	_	_	_	_	_
28	affects	affect	_	_	_	_	_	_	_
29	expression	expression	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	EBV	EBV	_	_	_	_	_	_	_
33	latent	latent	_	_	_	_	_	_	_
34	infection	infection	_	_	_	_	_	_	_
35	membrane	membrane	_	_	_	_	_	_	_
36	protein	protein	_	_	_	_	_	_	_
37	LMP1	lmp1	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	now	now	_	_	_	_	_	_	_
3	demonstrate	demonstrate	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	following.	following.	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	i	i	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	Acute	acute	_	_	_	_	_	_	_
10	transfection	transfection	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	expression	expression	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	EBNA-2	ebna-2	_	_	_	_	_	_	_
15	under	under	_	_	_	_	_	_	_
16	control	control	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	simian	simian	_	_	_	_	_	_	_
19	virus	virus	_	_	_	_	_	_	_
20	40	40	_	_	_	_	_	_	_
21	or	or	_	_	_	_	_	_	_
22	Moloney	Moloney	_	_	_	_	_	_	_
23	murine	murine	_	_	_	_	_	_	_
24	leukemia	leukemia	_	_	_	_	_	_	_
25	virus	virus	_	_	_	_	_	_	_
26	promoters	promoter	_	_	_	_	_	_	_
27	resulted	result	_	_	_	_	_	_	_
28	in	in	_	_	_	_	_	_	_
29	increased	increase	_	_	_	_	_	_	_
30	LMP1	lmp1	_	_	_	_	_	_	_
31	expression	expression	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	P3HR-1-infected	p3hr-1-infected	_	_	_	_	_	_	_
34	Burkitt	Burkitt	_	_	_	_	_	_	_
35	â€™s	's	_	_	_	_	_	_	_
36	lymphoma	lymphoma	_	_	_	_	_	_	_
37	cells	cell	_	_	_	_	_	_	_
38	and	and	_	_	_	_	_	_	_
39	the	the	_	_	_	_	_	_	_
40	P3HR-1	P3HR-1	_	_	_	_	_	_	_
41	or	or	_	_	_	_	_	_	_
42	Daudi	Daudi	_	_	_	_	_	_	_
43	cell	cell	_	_	_	_	_	_	_
44	line.	line.	_	_	_	_	_	_	_
45	(	(	_	_	_	_	_	_	_
46	ii	ii	_	_	_	_	_	_	_
47	)	)	_	_	_	_	_	_	_
48	Transfection	transfection	_	_	_	_	_	_	_
49	and	and	_	_	_	_	_	_	_
50	expression	expression	_	_	_	_	_	_	_
51	of	of	_	_	_	_	_	_	_
52	EBNA-LP	EBNA-LP	_	_	_	_	_	_	_
53	alone	alone	_	_	_	_	_	_	_
54	had	have	_	_	_	_	_	_	_
55	no	no	_	_	_	_	_	_	_
56	effect	effect	_	_	_	_	_	_	_
57	on	on	_	_	_	_	_	_	_
58	LMP1	lmp1	_	_	_	_	_	_	_
59	expression	expression	_	_	_	_	_	_	_
60	and	and	_	_	_	_	_	_	_
61	did	do	_	_	_	_	_	_	_
62	not	not	_	_	_	_	_	_	_
63	act	act	_	_	_	_	_	_	_
64	synergistically	synergistically	_	_	_	_	_	_	_
65	with	with	_	_	_	_	_	_	_
66	EBNA-2	ebna-2	_	_	_	_	_	_	_
67	to	to	_	_	_	_	_	_	_
68	affect	affect	_	_	_	_	_	_	_
69	LMP1	lmp1	_	_	_	_	_	_	_
70	expression.	expression.	_	_	_	_	_	_	_
71	(	(	_	_	_	_	_	_	_
72	iii	iii	_	_	_	_	_	_	_
73	)	)	_	_	_	_	_	_	_
74	LMP1	lmp1	_	_	_	_	_	_	_
75	expression	expression	_	_	_	_	_	_	_
76	in	in	_	_	_	_	_	_	_
77	Daudi	Daudi	_	_	_	_	_	_	_
78	and	and	_	_	_	_	_	_	_
79	P3HR-1-infected	p3hr-1-infected	_	_	_	_	_	_	_
80	cells	cell	_	_	_	_	_	_	_
81	was	be	_	_	_	_	_	_	_
82	controlled	control	_	_	_	_	_	_	_
83	at	at	_	_	_	_	_	_	_
84	the	the	_	_	_	_	_	_	_
85	mRNA	mrna	_	_	_	_	_	_	_
86	level	level	_	_	_	_	_	_	_
87	,	,	_	_	_	_	_	_	_
88	and	and	_	_	_	_	_	_	_
89	EBNA-2	ebna-2	_	_	_	_	_	_	_
90	expression	expression	_	_	_	_	_	_	_
91	in	in	_	_	_	_	_	_	_
92	Daudi	Daudi	_	_	_	_	_	_	_
93	cells	cell	_	_	_	_	_	_	_
94	increased	increase	_	_	_	_	_	_	_
95	LMP1	lmp1	_	_	_	_	_	_	_
96	mRNA.	mrna.	_	_	_	_	_	_	_
97	(	(	_	_	_	_	_	_	_
98	iv	iv	_	_	_	_	_	_	_
99	)	)	_	_	_	_	_	_	_
100	No	no	_	_	_	_	_	_	_
101	other	other	_	_	_	_	_	_	_
102	EBV	EBV	_	_	_	_	_	_	_
103	genes	gene	_	_	_	_	_	_	_
104	were	be	_	_	_	_	_	_	_
105	required	require	_	_	_	_	_	_	_
106	for	for	_	_	_	_	_	_	_
107	EBNA-2	ebna-2	_	_	_	_	_	_	_
108	transactivation	transactivation	_	_	_	_	_	_	_
109	of	of	_	_	_	_	_	_	_
110	LMP1	lmp1	_	_	_	_	_	_	_
111	since	since	_	_	_	_	_	_	_
112	cotransfection	cotransfection	_	_	_	_	_	_	_
113	of	of	_	_	_	_	_	_	_
114	recombinant	recombinant	_	_	_	_	_	_	_
115	EBNA-2	ebna-2	_	_	_	_	_	_	_
116	expression	expression	_	_	_	_	_	_	_
117	vectors	vector	_	_	_	_	_	_	_
118	and	and	_	_	_	_	_	_	_
119	genomic	genomic	_	_	_	_	_	_	_
120	LMP1	lmp1	_	_	_	_	_	_	_
121	DNA	dna	_	_	_	_	_	_	_
122	fragments	fragment	_	_	_	_	_	_	_
123	enhanced	enhance	_	_	_	_	_	_	_
124	LMP1	lmp1	_	_	_	_	_	_	_
125	expression	expression	_	_	_	_	_	_	_
126	in	in	_	_	_	_	_	_	_
127	the	the	_	_	_	_	_	_	_
128	EBV-negative	ebv-negative	_	_	_	_	_	_	_
129	B-lymphoma	B-lymphoma	_	_	_	_	_	_	_
130	cell	cell	_	_	_	_	_	_	_
131	lines	line	_	_	_	_	_	_	_
132	BJAB	BJAB	_	_	_	_	_	_	_
133	,	,	_	_	_	_	_	_	_
134	Louckes	Louckes	_	_	_	_	_	_	_
135	,	,	_	_	_	_	_	_	_
136	and	and	_	_	_	_	_	_	_
137	BL30.	BL30.	_	_	_	_	_	_	_
138	(	(	_	_	_	_	_	_	_
139	v	v	_	_	_	_	_	_	_
140	)	)	_	_	_	_	_	_	_
141	An	an	_	_	_	_	_	_	_
142	EBNA-2-responsive	ebna-2-responsive	_	_	_	_	_	_	_
143	element	element	_	_	_	_	_	_	_
144	was	be	_	_	_	_	_	_	_
145	found	find	_	_	_	_	_	_	_
146	within	within	_	_	_	_	_	_	_
147	the	the	_	_	_	_	_	_	_
148	-512	-512	_	_	_	_	_	_	_
149	to	to	_	_	_	_	_	_	_
150	+40	+40	_	_	_	_	_	_	_
151	LMP1	lmp1	_	_	_	_	_	_	_
152	DNA	dna	_	_	_	_	_	_	_
153	since	since	_	_	_	_	_	_	_
154	this	this	_	_	_	_	_	_	_
155	DNA	dna	_	_	_	_	_	_	_
156	linked	link	_	_	_	_	_	_	_
157	to	to	_	_	_	_	_	_	_
158	a	a	_	_	_	_	_	_	_
159	chloramphenicol	chloramphenicol	_	_	_	_	_	_	_
160	acetyltransferase	acetyltransferase	_	_	_	_	_	_	_
161	reporter	reporter	_	_	_	_	_	_	_
162	gene	gene	_	_	_	_	_	_	_
163	was	be	_	_	_	_	_	_	_
164	transactivated	transactivate	_	_	_	_	_	_	_
165	by	by	_	_	_	_	_	_	_
166	cotransfection	cotransfection	_	_	_	_	_	_	_
167	with	with	_	_	_	_	_	_	_
168	an	an	_	_	_	_	_	_	_
169	EBNA-2	ebna-2	_	_	_	_	_	_	_
170	expression	expression	_	_	_	_	_	_	_
171	vector.	vector.	_	_	_	_	_	_	_
172	(	(	_	_	_	_	_	_	_
173	vi	vi	_	_	_	_	_	_	_
174	)	)	_	_	_	_	_	_	_
175	The	the	_	_	_	_	_	_	_
176	EBV	EBV	_	_	_	_	_	_	_
177	type	type	_	_	_	_	_	_	_
178	2	2	_	_	_	_	_	_	_
179	EBNA-2	ebna-2	_	_	_	_	_	_	_
180	transactivated	transactivate	_	_	_	_	_	_	_
181	LMP1	lmp1	_	_	_	_	_	_	_
182	as	as	_	_	_	_	_	_	_
183	well	well	_	_	_	_	_	_	_
184	as	as	_	_	_	_	_	_	_
185	the	the	_	_	_	_	_	_	_
186	EBV	EBV	_	_	_	_	_	_	_
187	type	type	_	_	_	_	_	_	_
188	1	1	_	_	_	_	_	_	_
189	EBNA-2.	EBNA-2.	_	_	_	_	_	_	_
190	(	(	_	_	_	_	_	_	_
191	vii	vii	_	_	_	_	_	_	_
192	)	)	_	_	_	_	_	_	_
193	Two	two	_	_	_	_	_	_	_
194	deletions	deletion	_	_	_	_	_	_	_
195	within	within	_	_	_	_	_	_	_
196	the	the	_	_	_	_	_	_	_
197	EBNA-2	ebna-2	_	_	_	_	_	_	_
198	gene	gene	_	_	_	_	_	_	_
199	which	which	_	_	_	_	_	_	_
200	rendered	render	_	_	_	_	_	_	_
201	EBV	EBV	_	_	_	_	_	_	_
202	transformation	transformation	_	_	_	_	_	_	_
203	incompetent	incompetent	_	_	_	_	_	_	_
204	did	do	_	_	_	_	_	_	_
205	not	not	_	_	_	_	_	_	_
206	transactivate	transactivate	_	_	_	_	_	_	_
207	LMP1	lmp1	_	_	_	_	_	_	_
208	,	,	_	_	_	_	_	_	_
209	whereas	whereas	_	_	_	_	_	_	_
210	a	a	_	_	_	_	_	_	_
211	transformation-competent	transformation-competent	_	_	_	_	_	_	_
212	EBNA-2	ebna-2	_	_	_	_	_	_	_
213	deletion	deletion	_	_	_	_	_	_	_
214	mutant	mutant	_	_	_	_	_	_	_
215	did	do	_	_	_	_	_	_	_
216	transactivate	transactivate	_	_	_	_	_	_	_
217	LMP1	lmp1	_	_	_	_	_	_	_
218	.	.	_	_	_	_	_	_	_

1	LMP1	LMP1	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	potent	potent	_	_	_	_	_	_	_
5	effector	effector	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	B-lymphocyte	B-lymphocyte	_	_	_	_	_	_	_
8	activation	activation	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	can	can	_	_	_	_	_	_	_
11	act	act	_	_	_	_	_	_	_
12	synergistically	synergistically	_	_	_	_	_	_	_
13	with	with	_	_	_	_	_	_	_
14	EBNA-2	ebna-2	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	induce	induce	_	_	_	_	_	_	_
17	cellular	cellular	_	_	_	_	_	_	_
18	CD23	cd23	_	_	_	_	_	_	_
19	gene	gene	_	_	_	_	_	_	_
20	expression	expression	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Thus	thus	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	EBNA-2	ebna-2	_	_	_	_	_	_	_
4	transactivation	transactivation	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	LMP1	LMP1	_	_	_	_	_	_	_
7	amplifies	amplify	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	biological	biological	_	_	_	_	_	_	_
10	impact	impact	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	EBNA-2	ebna-2	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	underscores	underscore	_	_	_	_	_	_	_
15	its	its	_	_	_	_	_	_	_
16	central	central	_	_	_	_	_	_	_
17	role	role	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	EBV-induced	ebv-induced	_	_	_	_	_	_	_
20	growth	growth	_	_	_	_	_	_	_
21	transformation	transformation	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

